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Introduction
Temporomandibular joint disorder (TMD) is a general 
term for clinical problems in temporomandibular joints 
(TMJs), masticatory muscles, and surrounding tissues, 
which manifest as limitations in motion and joint sounds.1 
TMD is the second most-common skeletal- muscular 
problem and one of the most common chronic problems 
involving orofacial pain, discomfort and disability. 
Approximately 75% of the population has several 
symptoms of TMD and 33% have at least one symptom.2-5 
The etiology of TMD, especially muscle pain, is 
multifactorial and includes parafunctional habits, trauma, 
stress, heredity and occlusal factors5; thus, conservative 
and reversible treatment, especially during initial 
periods, is recommended.5,6 Several treatments have been 
suggested to control pain and symptoms. These include 
orthopedic stabilization, intraoral devices, medications 
(analgesics, muscle relaxants, antidepressants, and 
placebos) and physical therapy.5 The aim of physical 
therapy is muscle relaxation, a decrease in pain, spasms, 
swelling and inflammation, and joint stability.7 Massage, 
heat therapy, ultrasound, laser, and transcutaneous 
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Abstract
Introduction: Temporomandibular joint disorders (TMDs) are the most common source of pain 
on the face. There are multiple etiologies, and several types of treatment have been reported. The 
use of non-invasive and reversible therapies in the treatment of such problems is recommended. 
The present study evaluated the effect of low-level laser (LLL) therapy and transcutaneous electric 
nerve stimulation (TENS) on TMDs.
Methods: In this single-blind study, 40 patients with temporomandibular disorders were 
randomly divided into four groups: TENS (TENSTem dental), LLL (diode 810 nm CW), sham-
TENS, and sham-LLL. All subjects were examined and data on pain and tenderness in the 
temporomandibular joint (TMJ) and masticatory muscles (using the visual analogue scale) and 
mouth-opening (distance between incisal edges before feeling pain; mm) were collected before 
baseline (T1), after each session (T2-T5) and one month after the end of the sessions (T6)), and 
analyzed using repeated measure analysis of variance (ANOVA) and Bonferroni statistical tests. 
A P value < 0.05 was considered significant.
Results: The decrease in pain (P = 0.000), tenderness (P = 0.000) and increase in mouth-opening 
ability (P = 0.002) was greater in the TENS and LLL groups than in the placebo groups. At the 
one-month follow-up, significant decrease in pain and tenderness was recorded in the TENS 
and LLL groups (P = 0.000). There was no significant differences between TENS and LLL and the 
placebo groups for maximum mouth-opening at the end of the study (P = 0.692). 
Conclusion: Using TENS or LLL therapy can improve TMD symptoms at least for the short term. 
Although the effects of the placebo played a role in improving symptoms, their effects were less 
important. 
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electric nerve stimulation (TENS) have been used to 
control symptoms of TMD.7 
TENS is a relatively effective, economical, safe, and non-
invasive method of reducing acute and chronic pain.8 
The device causes relaxation of hyperactive muscles and 
decreases or eliminates pain through the application 
of electrical current via electrodes attached to the skin. 
Several theories have been advanced for its effectiveness. 
Direct stimulation of motor nerves can cause rhythmic 
contractions in muscles that increases blood flow and 
decreases muscle edema and hypoxia, which subsequently 
reduces pain. A second theory is based on the gate control 
theory in which the application of electrical current or 
pressure to afferent nerve fibers having larger diameters 
decreases or prevents the sending of impulses from 
afferent nerve fibers having smaller diameters by closing 
the pain gates in the spinal cord.8
The use of low-level laser (LLL) therapy has been 
growing because it is analgesic and anti-inflammatory. It 
usually excites tissues marked in red during treatment of 
musculoskeletal disorders with different radiation doses 
at infrared wavelengths.9,10 Its pain control mechanism is 
not well known; reports suggest that this may occur due 
to increased release of endogenous epions, improvement 
of area microcirculation, or an increase in lymphatic 
flow which reduces edema, increases the production 
of ATP, and reduces the permeability of nerve cells 
membranes.9,11,12 
Several studies have been conducted on the application 
of TENS and LLL therapy in patients with TMDs with 
conflicting results. The difference may result from various 
lengths of application, radiation dose, duration, or the 
parameters used to assess improvement. Kamyszek et 
al demonstrated that the use of TENS can significantly 
decrease muscle activity in patients with TMDs.13 
Treacy et al showed that muscular awareness relaxation 
training (MART) was more effective in reducing muscle 
activity and improving mouth-opening.14 Núñez et al 
revealed that mouth-opening in patients with TMDs 
increased following application of LLL therapy and 
TENS.15 Mazzetto et al showed that LLL therapy can be 
used as a supportive treatment in patients with TMDs to 
reduce pain and improve movement.11 The present study 
evaluated the effectiveness of LLL therapy and TENS on 
TMDs.
 
Materials and Methods
This single-blind clinical trial was conducted with 
patients referred to the School of Dentistry at Shahid 
Beheshti University of Medical Sciences, complaining of 
TMDs. After examination in accordance with the method 
presented by Dworkin et al,16 40 patients (aged 18-50 
years) presenting TMDs for which the source muscles 
were determined, were randomly divided into 4 groups. 
All patients complained of head and neck pain and 
tenderness on palpation, especially around the ears and 
during function, and showed limited mouth-opening. 
Patients with a history of recent trauma, dental pain, 
bleeding in the area, and neoplasia or systemic disease 
involving joints, such as osteoarthritis, rheumatoid 
arthritis, and diabetes, were excluded. Those with cardiac 
arrhythmia or pacemakers and pregnant patients were 
also excluded. Patients who had been receiving other 
treatments were asked to cease treatment one month 
before the start of the study. 
The purpose of the study, the use of the equipment, its 
benefits and risks and the chances of being in the control 
or study group were explained to the patients and they 
signed consent forms. They were then randomly divided 
into 4 groups (2 control and 2 study groups with 10 
patients per group). All subjects were examined and 
tenderness of the TMJ and masticatory muscles, including 
the masseter, temporalis, internal and external pterygoid 
(using the visual analog scale; VAS) and mouth-opening 
(distance between incisal edges until feeling pain; mm) 
were recorded.
In the TENS group, a TENSTem dental device (Schwa-
medico BV; The Netherlands) was applied via electrodes 
to the skin for 30 minutes at 500 W, a maximum frequency 
of 50 Hz and 15 mA output current. Patients sat in a 
comfortable chair in a quiet room during intervention. 
The methods used were those from Wessberg et al17 
and Geissler and McPhee18 as well as manufacturer 
instructions. A positive electrode was placed in the TMJ 
area ahead of and below the ear hole and an inert electrode 
was applied to the back of the neck. The patients were 
instructed to select the power of the device based on their 
own sensitivity and tolerance so that the process was not 
painful.19 In the sham-TENS group, the same procedure 
was applied, but the device was turned off.
In the LLL group, a gallium-aluminum-arsenide 
diode source (Doctor Smile Diode Laser; Italy) with a 
wavelength of 810 nm, a continuous 0.5 W peak power 
output beam and a 5-mm spot size was used. The total 
amount of irradiation time per painful point was 60 
seconds. In the sham-LLL group, the same procedure was 
followed at the same setting but the device was turned 
off. The intervention period was four half-hour sessions 
per week. In order to assess pain and the tenderness 
of masticatory muscles, VAS was used as the baseline 
(T1), and after each session (T2-T5). Mouth-opening 
was recorded in the same manner for all groups. One 
month after completion of the sessions, the patients were 
examined to determine the sensitivity in the masticatory 
muscles and TMJ and maximum mouth-opening, and 
the results were recorded (T6). Data was evaluated using 
SPSS (version 21) and the repeated measure analysis of 
variance (ANOVA), as well as Bonferroni tests (multiple 
comparisons between groups and times were performed 
using Bonferroni adjustment) were carried out.
Results
Kolmogorov-Smirnov statistical analysis showed that 
the variables examined followed a normal distribution. 
One-way ANOVA demonstrated that maximum 
mouth-opening (P = 0.884), muscle pain (P = 0.484) and 
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tenderness (P = 0.933) were matched before the study, 
and no significant difference was observed between the 
groups.
Maximum Mouth-Opening
In all groups, mouth-opening improved over time so 
that maximum mouth-opening was recorded after the 
last intervention (T5); however, after one month, the 
improvement compared to baseline was not significant 
(P = 0.192). There was no significant difference between 
the LLL and TENS groups (P = 0.820) at all stages (T1-
T6). The effectiveness of the placebos were also identical 
and no significant difference was observed between 
the groups (P = 0.738) (Table 1). Mouth-opening in the 
intervention groups (TENS and LLL) was significantly 
greater than for the placebo groups after T3 (P = 0.002), 
but not by the one-month follow-up (P = 0.692). 
Pain
In the intervention groups (TENS and LLL) pain 
significantly decreased after T2 and continued until the 
one month follow-up (P = 0.000). The greatest decrease in 
pain was achieved by the TENS group after T5; however, 
the difference was not significant (P = 0.12). In the placebo 
groups, pain significantly decreased after T4; however, 
at the one-month follow-up, there was no significant 
difference with baseline (P = 0.692; Table 1). 
Tenderness of Masticatory Muscles and TMJ Area 
Patients in the TENS and LLL groups recorded significantly 
less tenderness after the first intervention (T2), which 
continued to the one-month follow-up (T6; P = 0.000). 
The greatest decrease in tenderness was achieved by the 
TENS group after T5; however, the difference between 
groups was not significant at all stages (P = 0.08). In 
the sham groups, the least amount of tenderness was 
recorded after T5, and there was no significant difference 
with the baseline (T1) at the 30-day follow-up (P = 0.83). 
After intervention, the decrease in tenderness in the 
intervention groups was greater than for the sham groups 
at all stages (P = 0.000).
Discussion 
Various methods have been reported for the management 
and treatment of TMDs; however, the use of noninvasive 
interventions is recommended in most cases.20 The TENS 
device is often used in dentistry to control chronic pain 
and relax masticatory muscles. It is also used in the 
treatment of trigeminal neuralgia, migraine, and muscle 
contractions.21 In recent years, LLL therapy has been used 
for the management of musculoskeletal pain, wound 
healing, and inflammation.22 
The psychological aspects of TMJ problems treatment 
are important; the effect of placebos in treatment can 
be effective in over 40% of patients.23 For this reason, 
the present study used separate groups with almost the 
same pre-treatment conditions as placebo groups. Several 
studies have examined the effectiveness of LLL and TENS 
for patients with TMD. Wessberg et al,17 Møystad et al,24 
Hansson and Ekblom,25 Wieselmann-Penkner et al,26 Lewis 
et al27 and Marchand et al28 discussed the effectiveness of 
TENS in pain reduction and improving joint symptoms 
and other muscle aches. Several studies showed that LLL 
can reduce the pain in TMD patients.4,10-12,22,29,32-35 
Maximum mouth-opening, pain, and muscle tenderness 
were the criteria recorded in the present study. After the 
last session, mouth-opening had significantly decreased 
in all groups. The greatest improvement occurred in the 
TENS group (29.11% recovery), followed by the LLL 
(24.7%), sham-TENS (11.33%) and sham-LLL (8.27%) 
Table 1. Mean (Standard Deviation) of Maximum Mouth Opening, Pain and Tenderness in Millimeters Separated in Different Groups of 
Intervention
Evaluation
T1 (Before 
Intervention)
T2 (1st 
Intervention)
T3 (2nd 
Intervention)
T4 (3rd  
Intervention)
T5 (4th 
Intervention)
T6 (30 Days 
Fallow up)
MMO*
TENS 35.20 (2.48) 38.70 (2.29) 40.25 (3.09) 43.20 (2.80) 45.45 (1.93) 37.30 (2.10)
Sham TENS 35.30 (1.78) 37.55 (2.35) 38.20 (2.39) 39.25 (2.61) 39.30 (2.020 37.55 (1.84)
LLL 36.20 (2.87) 39.50 (2.65) 41.13 (2.95) 44.92 (2.79) 45.15 (2.34) 38.11 (2.33)
Sham LLL 35.90 (1.64) 37.25 (1.99) 37.80 (2.21) 38.15 (2.29) 38.87 (2.23) 36.99 (1.34)
Pain
TENS 44.95 (5.74) 33.17 (4.73) 28.80 (4.79) 23.55 (3.77) 14.70 (6.50) 32.05 (5.64)
Sham TENS 43.73 (5.16) 39.75 (5.32) 38.99 (4.72) 36.40 (4.71) 36.55 (5.78) 40.45 (4.31)
LLL 44.58 (4.34) 34.15 (5.25) 30.24 (3.54) 29.35 (3.22) 17.67 (5.27) 34.29 (4.34)
Sham LLL 44.24 (3.32) 40.13 (3.12) 39.99 (4.18) 38.10 (3.12) 37.15 (4.58) 41.26 (5.11)
Tenderness
TENS 38.60 (4.05) 30.35 (6.36) 28.35 (5.22) 25.85 (4.51) 17.80 (4.12) 22.55 (4.27)
Sham TENS 38.70 (3.35) 35.35 (4.91) 34.25 (4.37) 32.45 (5.04) 32.20 (5.46) 36.75 (3.52)
LLL 39.83 (4.32) 32.25 (5.67) 30.46 (4.89) 28.88 (3.76) 20.57 (3.310 24.11 (4.13)
Sham LLL 38.12 (2.62) 35.16 (3.33) 34.15 (3.17) 33.45 (3.44) 31.78 (4.26) 36.23 (3.22)
Abbreviations: MMO, maximum mouth opening.
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groups. Muscle pain and tenderness were measured 
by VAS on palpation. The most effective treatment for 
decreasing pain was the TENS group (67.29% reduction) 
followed by the LLL (60.36%), sham-TENS (16.41%) 
and sham-LLL (16.02%) groups. The greatest decrease 
in tenderness was also obtained by the TENS (53.88% 
reduction) group followed by LLL (48.11%), sham-TENS 
(16.79%), and sham-LLL (16.63%) groups. At the end of 
active treatment, both TENS and LLL were more effective 
than the placebo groups. These results are consistent 
with those of Gray et al36 and Lewis et al.27 At T4 and T5, 
TENS was more effective than LLL on pain reduction 
and muscle tenderness, but this was not statistically 
significant. A common mechanism such as an increase in 
regional blood flow and a decrease in the permeability of 
the nerve cell membrane and gate control theory of pain 
have been considered for both LLL and TENS devices to 
explain the similar tissue reactions.8,9,11
One month after the last intervention, all parameters 
were evaluated again. As expected, the improvement rate 
was lower than for the most recently recorded status. 
Maximum mouth-opening at the one-month follow-up 
was statistically similar to baseline in all groups. Pain and 
tenderness had also increased; however, in both the LLL 
and TENS groups, there was a significant improvement 
over the baseline. In the placebo groups, no difference 
was observed. The multifactorial nature of TMD may 
explain these changes. 
Assessing the reliability of objective criteria is easier 
than for subjective criteria. Pain and tenderness was 
reported using the VAS scale by patients (subjective) and 
mouth-opening was measured using a ruler by clinicians 
(objective). At the 1-month follow-up for both the LLL 
and TENS groups, patients had less pain and tenderness, 
but a lower mouth-opening ability. 
The placebo effect played a greater role in treatment, 
muscle pain and tenderness. At T5, these variables had 
improved compared to baseline in all groups. Lewis et 
al demonstrated that at 3 weeks after applying TENS 
and placebo-TENS, the TENS recovery rate was higher; 
however, 43% of patients receiving the placebo also 
showed a reduction in pain.27 In a double-blind study, 
Abreu Venancio et al evaluated the effect of LLL and 
placebo on pain, tenderness of masticatory muscles and 
maximum mouth-opening. Their results showed no 
significant difference between the two groups.9 Hansson 
and Ekblom, in contrast, found that after the use of 
TENS, 16 of 42 patients experienced a decrease in pain of 
more than 50%, while in the sham group, only 2 patients 
showed a decrease. They stated that the effectiveness of 
TENS is also influenced by the placebo effect,25 which 
is consistent with the findings of the present study. The 
placebo effect may result from the use of high-tech devices 
such as TENS or LLL as well as its application by an expert 
physician; however, the short-term effects of therapy and 
regenerative intervention should not be ignored.
The efficacy of TENS and LLL therapy in reducing 
symptoms of TMD was similar; in other words, both 
methods were equally effective. Núñez et al15 and Kato et 
al37 reported the effectiveness of TENS and LLL for TMD, 
but found that for some parameters, the effect of LLL was 
greater than for TENS. In the present study, although there 
was no significant difference, TENS was found to be more 
effective than LLL. This could result from differences in 
the radiation dose, duration, and irradiated area. Each 
intervention had limitations and advantages. Although 
the use of TENS is easier than LLL because of the smaller 
size involved, decreased risk and portability of the devise, 
electrical currents delivered to the skin through the TENS 
may cause discomfort in some patients.
Conclusion
The use of TENS or LLL can improve TMD symptoms, 
at least for the short term. Either TENS or LLL can 
be considered as an alternative physical modality 
or supplementary approach for management of 
temporomandibular disorder. The effects of the placebo 
in improving symptoms played a limited role. The present 
study did not evaluated the long term effect of treatment 
and there is need to design a study with longer follow-ups. 
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